...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: And we wait.....

"....nope,,,we have gained nothing by creating NewCo,,,,,,,,,nada,,,,,,,zippo,,+,,my trading account confirms that,,,,,,,,,!!!...."

If you're not seeing any value in those ZEN shares, perhaps you wouldn't mind transferring them to my account?  I'll give you $50 for your troubles.

Share
New Message
Please login to post a reply